Opportunities for biomaterials to address the challenges of COVID-19.

ABSTRACT: The coronavirus disease 2019 (COVID-19) pandemic has revealed major shortcomings in our ability to mitigate transmission of infectious viral disease and provide treatment to patients, resulting in a public health crisis. Within months of the first reported case in China, the virus has spread worldwide at an unprecedented rate. COVID-19 illustrates that the biomaterials community was engaged in significant research efforts against bacteria and fungi with relatively little effort devoted to viruses. Accordingly, biomaterials scientists and engineers will have to participate in multidisciplinary antiviral research over the coming years. Although tissue engineering and regenerative medicine have historically dominated the field of biomaterials, current research holds promise for providing tran

SUBMITTER: Chakhalian D 

PROVIDER: S-EPMC7405498 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature